feed,title,long_url,short_url
Investing,Strategy Earnings Reveal the Real Risk Behind MSTR Stock,https://www.investing.com/analysis/strategy-earnings-reveal-the-real-risk-behind-mstr-stock-200674611,
Investing,Garner-backed Once Upon a Farm surges in market debut,https://www.investing.com/news/stock-market-news/garnerbacked-once-upon-a-farm-surges-in-market-debut-4491574,
Investing,Once Upon a Farm stock jumps in NYSE debut after Jennifer Garner-backed IPO,https://www.investing.com/news/stock-market-news/once-upon-a-farm-stock-jumps-in-nyse-debut-after-jennifer-garnerbacked-ipo-93CH-4491570,
Investing,Jennifer Garner’s Once Upon a Farm valued at $845 million in NYSE debut,https://www.investing.com/news/stock-market-news/jennifer-garners-once-upon-a-farm-valued-at-845-million-in-nyse-debut-4491568,
Investing,Spyglass Pharma shares surge 50% in Nasdaq debut,https://www.investing.com/news/stock-market-news/spyglass-pharma-shares-surge-50-in-nasdaq-debut-93CH-4491560,
Investing,Analysis-Glencore to focus on short-term disposals as Rio deal remains elusive,https://www.investing.com/news/stock-market-news/analysisglencore-to-focus-on-shortterm-disposals-as-rio-deal-remains-elusive-4491558,
Investing,Belgium’s Agomab Therapeutics valued at $716 million as shares fall in Nasdaq debut,https://www.investing.com/news/stock-market-news/belgiums-agomab-therapeutics-valued-at-716-million-as-shares-fall-in-nasdaq-debut-4491557,
